BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 59 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $436,042 | -3.3% | 425,000 | 0.0% | 0.00% | – |
| Q4 2022 | $451,053 | +7.1% | 425,000 | 0.0% | 0.00% | – |
| Q3 2022 | $421,000 | 0.0% | 425,000 | 0.0% | 0.00% | – |
| Q2 2022 | $421,000 | -0.9% | 425,000 | 0.0% | 0.00% | – |
| Q1 2022 | $425,000 | -4.3% | 425,000 | 0.0% | 0.00% | – |
| Q4 2021 | $444,000 | +2.1% | 425,000 | 0.0% | 0.00% | – |
| Q3 2021 | $435,000 | -1.1% | 425,000 | 0.0% | 0.00% | – |
| Q2 2021 | $440,000 | -40.1% | 425,000 | -41.4% | 0.00% | – |
| Q1 2021 | $734,000 | -5.7% | 725,000 | 0.0% | 0.00% | – |
| Q4 2020 | $778,000 | +2.2% | 725,000 | 0.0% | 0.00% | – |
| Q3 2020 | $761,000 | -37.7% | 725,000 | -27.5% | 0.00% | – |
| Q2 2020 | $1,222,000 | +16.6% | 1,000,000 | 0.0% | 0.00% | – |
| Q1 2020 | $1,048,000 | -0.9% | 1,000,000 | 0.0% | 0.00% | – |
| Q4 2019 | $1,057,000 | -34.8% | 1,000,000 | -39.4% | 0.00% | – |
| Q3 2019 | $1,622,000 | -5.3% | 1,650,000 | 0.0% | 0.00% | – |
| Q2 2019 | $1,713,000 | -37.6% | 1,650,000 | -38.5% | 0.00% | -100.0% |
| Q1 2019 | $2,747,000 | +2.9% | 2,685,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $2,670,000 | -1.2% | 2,685,000 | +5.9% | 0.00% | 0.0% |
| Q3 2018 | $2,702,000 | +158.3% | 2,535,000 | +144.9% | 0.00% | – |
| Q2 2018 | $1,046,000 | – | 1,035,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 23,984,000 | $24,566,321 | 1.87% |
| SSI INVESTMENT MANAGEMENT LLC | 14,019,000 | $14,383,199 | 1.01% |
| PFM Health Sciences, LP | 15,000,000 | $15,427,185 | 0.68% |
| Sonora Investment Management Group, LLC | 6,380,000 | $6,460,377 | 0.56% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 24,638,000 | $25,339,666 | 0.48% |
| Lombard Odier Asset Management (Europe) Ltd | 9,000,000 | $9,099,180 | 0.45% |
| RWC Asset Management LLP | 11,700,000 | $12,018,591 | 0.37% |
| MACKAY SHIELDS LLC | 10,450,000 | $10,721,491 | 0.29% |
| PALISADE CAPITAL MANAGEMENT, LP | 10,093,000 | $10,326,148 | 0.28% |
| Nicholas Investment Partners, LP | 2,940,000 | $3,016,378 | 0.23% |